We are live on ! Find out more
BLC

Brown, Lisle/Cummings Portfolio holdings

AUM $400M
1-Year Est. Return 18.79%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+18.79%
3 Year Est. Return
+61.76%
5 Year Est. Return
10 Year Est. Return
AUM
$224M
AUM Growth
+$26.5M
Cap. Flow
+$16.5M
Cap. Flow %
7.39%
Top 10 Hldgs %
27.71%
Holding
558
New
25
Increased
144
Reduced
58
Closed
2

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$256K
2
BUD icon
AB InBev
BUD
+$191K
3
GE icon
GE Aerospace
GE
+$138K
4
GILD icon
Gilead Sciences
GILD
+$108K
5
INTC icon
Intel
INTC
+$72.9K

Sector Composition

Rank Sector Weight
1 Healthcare 17.74%
2 Technology 16.33%
3 Financials 12.83%
4 Industrials 8.85%
5 Communication Services 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$11.9M 5.31%
26,774
+142
+0.5% +$59.6K
AAPL icon
2
Apple
AAPL
$4.72T
$8.08M 3.61%
41,660
+1,490
+4% +$260K
MSFT icon
3
Microsoft
MSFT
$2.83T
$6.89M 3.08%
20,235
+971
+5% +$304K
ACN icon
4
Accenture
ACN
$84.9B
$6.39M 2.86%
20,706
+1,375
+7% +$400K
ICE icon
5
Intercontinental Exchange
ICE
$81B
$5.9M 2.64%
52,150
+3,695
+8% +$400K
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$3.88T
$5.3M 2.37%
44,275
+3,345
+8% +$385K
AMZN icon
7
Amazon
AMZN
$2.51T
$4.79M 2.14%
36,755
+1,725
+5% +$197K
AMGN icon
8
Amgen
AMGN
$201B
$4.73M 2.12%
21,302
+2,573
+14% +$597K
CNI icon
9
Canadian National Railway
CNI
$79.2B
$4.08M 1.82%
33,668
+11,675
+53% +$1.38M
VEEV icon
10
Veeva Systems
VEEV
$29.2B
$3.92M 1.75%
19,818
+130
+0.7% +$23.7K
SUB icon
11
iShares Short-Term National Muni Bond ETF
SUB
$11.3B
$3.87M 1.73%
37,237
WPC icon
12
W.P. Carey
WPC
$16.7B
$3.86M 1.73%
58,320
+9,011
+18% +$626K
BSX icon
13
Boston Scientific
BSX
$64.8B
$3.77M 1.69%
69,692
+6,625
+11% +$346K
BRK.B icon
14
Berkshire Hathaway Class B
BRK.B
$1.06T
$3.37M 1.51%
9,890
+625
+7% +$204K
TROW icon
15
T. Rowe Price
TROW
$24.6B
$3.35M 1.5%
29,900
+7,430
+33% +$814K
FISV
16
Fiserv Inc
FISV
$26.6B
$3.31M 1.48%
26,250
-425
-2% -$50K
JPM icon
17
JPMorgan Chase
JPM
$930B
$3.16M 1.41%
21,737
+6,776
+45% +$932K
TMO icon
18
Thermo Fisher Scientific
TMO
$213B
$2.99M 1.34%
5,733
+235
+4% +$127K
GOOG icon
19
Alphabet (Google) Class C
GOOG
$3.88T
$2.88M 1.29%
23,837
ABBV icon
20
AbbVie
ABBV
$454B
$2.84M 1.27%
21,067
+1,125
+6% +$165K
NVO
21
Novo Nordisk
NVO
$213B
$2.72M 1.22%
33,590
-430
-1% -$35.1K
MRSH
22
Marsh
MRSH
$84.2B
$2.3M 1.03%
12,233
+337
+3% +$59.8K
MRK icon
23
Merck
MRK
$322B
$2.25M 1.01%
19,495
+2,895
+17% +$329K
MINT icon
24
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
$2.17M 0.97%
21,801
-200
-0.9% -$19.9K
ECL icon
25
Ecolab
ECL
$74.1B
$2.14M 0.96%
11,470
+25
+0.2% +$4.3K

Similar funds

Brown, Lisle/Cummings's Q2 2023 Portfolio in Review

As of Q2 2023, Brown, Lisle/Cummings held 558 positions worth $224M, up 13% from $197M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Brown, Lisle/Cummings deployed $16.5M of net new capital in Q2 2023, opening 25 new positions and adding to 144 existing holdings. Its largest new stake was Charles Schwab: 12,150 shares worth $689K.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $256K trimmed.

  • Brown, Lisle/Cummings's largest Q2 2023 buy was Charles Schwab: 12,150 shares worth $689K.
  • Brown, Lisle/Cummings added most to Canadian National Railway in Q2 2023, an estimated $1.38M increase.
  • Brown, Lisle/Cummings's biggest Q2 2023 reduction was Bristol-Myers Squibb, cutting an estimated $256K.
  • Brown, Lisle/Cummings fully exited J.M. Smucker in Q2 2023, selling an estimated $15.7K.
  • Brown, Lisle/Cummings's ten largest holdings make up 28% of its $224M portfolio in Q2 2023.
  • Brown, Lisle/Cummings opened 25 new positions and closed 2 in Q2 2023.
  • Brown, Lisle/Cummings's portfolio value rose 13% quarter-over-quarter to $224M.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2023, filed 1 Jul 2024.